G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon
Authors:
- Jamille G. DombrowskiJDJamille G. Dombrowski
- Rodrigo M. SouzaRSRodrigo M. Souza
- Jonathan CurryJCJonathan Curry
- Laura HintonLHLaura Hinton
- Natercia R. M. SilvaNSNatercia R. M. Silva
- Lynn GrignardLGLynn Grignard
- Ligia A. GonçalvesLGLigia A. Gonçalves
- Ana Rita GomesAGAna Rita Gomes
- Sabrina EpiphanioSESabrina Epiphanio
- Chris DrakeleyCDChris Drakeley
- Jim HuggettJHJim Huggett
- Taane G. ClarkTaane G. Clark
Open Access
- 15 June 2017
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 16 (1) , 1-9
Abstract
Plasmodium vivax parasites are the predominant cause of malaria infections in the Brazilian Amazon. Infected individuals are treated with primaquine, which can induce haemolytic anaemia in glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals and may lead to severe and fatal complications. This X-linked disorder is distributed globally and is caused by allelic variants with a geographical distribution that closely reflects populations exposed historically to endemic malaria. In Brazil, few studies have reported the frequency of G6PD deficiency (G6PDd) present in malaria-endemic areas. This is particularly important, as G6PDd screening is not currently performed before primaquine treatment. The aim of this study was to determine the prevalence of G6PDd in the region of Alto do Juruá, in the Western Brazilian Amazon, an area characterized by a high prevalence of P. vivax infection. Five-hundred and sixteen male volunteers were screened for G6PDd using the fluorescence spot test (Beutler test) and CareStart™ G6PD Biosensor system. Demographic and clinical-epidemiological data were acquired through an individual interview. To assess the genetic basis of G6PDd, 24 SNPs were genotyped using the Kompetitive Allele Specific PCR assay. Twenty-three (4.5%) individuals were G6PDd. No association was found between G6PDd and the number of malaria cases. An increased risk of reported haemolysis symptoms and blood transfusions was evident among the G6PDd individuals. Twenty-two individuals had the G6PDd A(−) variant and one the G6PD A(+) variant. The Mediterranean variant was not present. Apart from one polymorphism, almost all SNPs were monomorphic or with low frequencies (0–0.04%). No differences were detected among ethnic groups. The data indicates that ~1/23 males from the Alto do Juruá could be G6PD deficient and at risk of haemolytic anaemia if treated with primaquine. G6PD A(−) is the most frequent deficiency allele in this population. These results concur with reported G6PDd in other regions in Brazil. Routine G6PDd screening to personalize primaquine administration should be considered, particularly as complete treatment of patients with vivax malaria using chloroquine and primaquine, is crucial for malaria elimination.Keywords
Funding Information
- National Counsel of Technological and Scientific Development (475762/2013-4)
- São Paulo Research Foundation (2014/09964-5, 2014/20451-0)
- FAPESP fellowships (2012/04755-3, 2016/13465-0)
- FAPESP Visitor Researcher fellowships (2015/06106-0)
- CAPES/PROEX
- Medical Research Council (MC_PC_15103, MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103)
This publication has 34 references indexed in Scilit:
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based MapPLOS Medicine, 2012
- Underlying Factors Associated with Anemia in Amazonian Children: A Population-Based, Cross-Sectional StudyPLOS ONE, 2012
- Costs and cost-effectiveness of malaria control interventions - a systematic reviewMalaria Journal, 2011
- Glucose-6-phosphate-dehydrogenase deficiency and its correlation with other risk factors in jaundiced newborns in Southern BrazilAsian Pacific Journal of Tropical Biomedicine, 2011
- Glucose-6-Phosphate Dehydrogenase Deficiency in an Endemic Area for Malaria in Manaus: A Cross-Sectional Survey in the Brazilian AmazonPLOS ONE, 2009
- A novel point mutation in a class IV glucose-6-phosphate dehydrogenase variant (G6PD São Paulo) and polymorphic G6PD variants in São Paulo State, BrazilGenetics and Molecular Biology, 2009
- Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibilityEuropean Journal of Human Genetics, 2009
- X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe MalariaPLOS Medicine, 2007
- Atividade da 6-fosfogliconato desidrogenase em deficientes de glicose-6-fosfato desidrogenaseRevista Brasileira de Ginecologia e Obstetrícia, 2006
- Avaliação da incidência da deficiência de Glicose-6-Fosfato Desidrogenase (G6PD) e perfil hematológico em indivíduos de uma região de RondôniaRevista Brasileira de Ginecologia e Obstetrícia, 2004